Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 11—November 2011
Letter

Reduced Susceptibility to Vancomycin in Staphylococcus aureus

Cite This Article

To the Editor: I read with interest the article by Aguado et al. (1). I congratulate the authors for their high-quality research and would like to make 2 brief comments.

My first point regards the mechanism by which methicillin-susceptible Staphylococcus aureus (MSSA) with reduced susceptibility to vancomycin would also acquire decreased susceptibility to β-lactams. The authors “hypothesize that certain structural modifications might also occur in the cell wall of strains with high vancomycin MIC, including a thicker cell wall as it has been described in MRSA [methicillin-resistant S. aureus].” In addition to cell wall thickening, possible mechanisms could include reduction in autolysis (2,3) and in the cell wall content of penicillin binding protein 4 (PBP4) (3). A study of MSSA isolates has shown a reduction in autolysis and in the bactericidal activity of oxacillin after development of intermediate vancomycin susceptibility (2). Lower content of PBP4 and decreased autolysis were reported in MRSA isolates after reduced susceptibility to vancomycin developed after exposure to this antimicrobial drug (3). Decreased PBP4 has been associated with reduced methicillin susceptibility in S. aureus (4).

Second, knowing whether the authors had the exact vancomycin MIC of the isolates by broth microdilution to compare with the Etest results would be interesting. In the article, they only state that “all 99 MSSA strains were susceptible to vancomycin (MIC <2 μg/mL) by the broth microdilution method.” Although difficult to compare (because Etest dilution progression is arithmetic and broth microdilution is performed with a geometric dilution), some authors have found substantial differences between the vancomycin MIC results given by these 2 methods (5). These differences could have major laboratory and clinical implications.

Top

Marcelo J. Mimica

Author affiliation: Santa Casa School of Medicine, São Paulo, Brazil

Top

References

  1. Aguado  JM, San-Juan  R, Lalueza  A, Sanz  F, Rodríguez-Otero  J, Gómez-Gonzalez  C, High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerg Infect Dis. 2011;17:1099102. DOIPubMed
  2. Pillai  SK, Wennersten  C, Venkataraman  L, Eliopoulos  G, Moellering  R, Karchmer  A. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis. 2009;49:116974. DOIPubMed
  3. Sieradzki  K, Tomasz  A. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol. 2003;185:710310. DOIPubMed
  4. Wyke  AW, Ward  JB, Hayes  MV, Curtis  NA. A role in vivo for penicillin-binding protein-4 of Staphylococcus aureus. Eur J Biochem. 1981;119:38993. DOIPubMed
  5. Mason  EO, Lamberth  LB, Hammerman  WA, Hulten  KG, Versalovic  J, Kaplan  SL. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009;47:162830. DOIPubMed

Top

Cite This Article

DOI: 10.3201/eid1711.110799

Related Links

Top

Table of Contents – Volume 17, Number 11—November 2011

Page created: October 27, 2011
Page updated: October 27, 2011
Page reviewed: October 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external